Have you met Robert Clark? Do you know his reputation here in the US? It’s obvious you have no perspective on the significance of his appointment.
One of the issues is many comments on this thread are not researched opinion or fact. If IXHL was trading at 70c again I imagine you’d hold a completely different view about Robert Clark, the placement at 20.5c and a myriad of other complaints. In the absence of research it’s the share price that determines your opinion.
There are many factors driving the current share price. Robert Clark is not one of them and neither are the fundamentals of the company.
In my short time on this forum I’ve realised the majority of posters are short term traders pretending to be investors and they typically have little to no fundamental understanding. The US market is going to rip the head off this stock on positive news and once the assets are sufficiently de-risked there’s every chance this company will get acquired.
Again, what is an OSA drug worth? Someone please answer that question.
IHL Price at posting:
7.4¢ Sentiment: Buy Disclosure: Held
